Armistice Capital, LLC 13D/13G Filings for Cyclacel Pharmaceuticals, Inc. (CYCC)

Armistice Capital, LLC 13D and 13G filings for Cyclacel Pharmaceuticals, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		 Transaction
Date		 Type Company
Symbol		 Filed By
Symbol		 Shares Owned
% Owned		 Shares Vs. Prev Report View
2025-05-15
3:24 pm
Purchase		 2025-03-31 13G Cyclacel Pharmaceuticals, Inc.
CYCC		 Armistice Capital, LLC 24,844,725
9.200%		 24,003,030increase
(+2851.75%)		 Filing
2025-02-14
5:40 pm
Purchase		 2024-12-31 13G Cyclacel Pharmaceuticals, Inc.
CYCC		 Armistice Capital, LLC 52,606
9.990%		 38,690increase
(+278.03%)		 Filing
2024-11-14
3:27 pm
Purchase		 2024-09-30 13G Cyclacel Pharmaceuticals, Inc.
CYCC		 Armistice Capital, LLC 13,916
9.990%		 13,916increase
(New Position)		 Filing